Homepage

Sandoz HACk White Paper

White Paper outlines importance of digital solutions to local healthcare problems.

Stories / Access to Healthcare

Educating patients and students – a day in the life of a doctor in South Africa (6 min read)

Get insights into the experiences of a healthcare professional in South Africa in this second episode ...

Stories / Access to Medicines

Biosimilars – Ten years of increasing access to state-of-the-art therapies (9 min read)

A tenth anniversary could be a fairly unremarkable date in healthcare, but 2016 marked the coming of ...

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine

Explore Novartis

About Us

Who We Are

Our Work

What We Do

About Us

Corporate Responsibility

Careers

Job Search

Recent Updates

Featured / Apr 20

Sandoz HACk White Paper: From fledgling to high-flyer (5min read)

With the release of a White Paper, the Sandoz Healthcare Challenge (HACk) – a competition that asked young ...

Learn More

View All

Media Release / Apr 19

Novartis delivered a strong first quarter and acted to become a more focused medicines company

Read More

Media Release / Apr 07

Sandoz outlines plans for next Healthcare Access Challenge (HACk), to support local digital innovation

Read More

Media Release / Mar 23

Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

Read More

Media Release / Feb 13

Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis

Read More

View All

@sandoz_global

We are looking forward to the 16th Biosimilar Medicines Conference #BIOS18 which starts tomorrow in London. What is… https://t.co/BLH4YOg527 16 hours 32 min ago

Follow Us

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More